KNG1 and Alzheimer disease: There is now abundant evidence (with a 15-year hiatus) that the aforementioned observations regarding the bradykinin-forming pathway are seen in patients with Alzheimer’s disease, with some evidence that activation is more readily observed in more severely affected subjects.